Results from a prospective study into long term functional and quality of life outcomes in patients with chronic ulcerative colitis (UC) who had IPAA are published in October's issue of Annals of Surgery
Persistent ascites and low serum sodium identify patients with cirrhosis as having a high mortality risk despite low MELD scores, states a report published in the most recent issue of Hepatology.
Serum bilirubin levels vary with gender, race, smoking status and are inversely correlated with nondermatological malignancy, reports this October's issue of Hepatology.
The New England Journal of Medicine reports that patients with HBeAg-negative chronic hepatitis B given peginterferon alfa – 2a, had higher rates of response than those given lamivudine alone
A report published in this October's issue of Hepatology finds that increased portal pressure estimated by early HVPG measurement is a main determinant of treatment failure and survival in variceal bleeding.
October's issue of Liver Transplantation provides a report into liver transplantation as a therapeutic option for HIV positive patients infected with hepatitis C or B.
Patient-reported family cancer histories for first-degree relatives are accurate and valuable for breast and colon cancer risk assessments, reports this week's issue of The Journal of American Medical Association
This month's Hepatology reports that a "Drug-Induced Liver Injury Network" (DILIN) has been set up to include 5 clinical centers in America in order to advance understanding and research on drug-induced liver disease.
The most recent issue of the International Journal of Colorectal Disease reports a surprising outcome in the trial examining gentamycin sponges for reduction of postoperative morbidity in rectal cancer patients.
Researchers in America report on the effect that competing risks have on the observed rate of fibrosis progression of chronic hepatitis C (CHC), in the most recent issue of Gastroenterology
Researchers in Manchester suggest that food elimination based on IgG antibodies may be effective in reducing IBS symptoms and is worthy of further biomedical research, reports this September's issue of Gut.
The results of a 2 year trial of 6-mercaptopurine and mesalamine in preventing postoperative recurrence of Crohn's disease have been published in this month's issue of Gastroenterology
In September's issue of Gut, the results of a follow up study into endoscopic and histologic procedures used in cases of suspicion of Barrett's esophagus are published.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .